为解决传统 BRCA1 检测方法的局限，伊朗研究人员开展纳米材料基生物传感器用于乳腺癌诊断的研究。结果显示这类传感器有高灵敏度等优势。推荐科研读者阅读，助力探索乳腺癌诊断新方向。 在全球范围内，乳腺癌就像一个 “健康杀手”，严重威胁着人们的生命健康。2020 年，全球大约有 230 万新的乳腺癌病例，68.5 万人因乳腺癌离世。而且，不同国家的乳腺癌发病率和死亡率差异很大，比如比利时每 10 ...

Pharmacogenomics. 2012;13(13):1523-1535. 5-year survival for stage III and IV (%): carriers, 38.1; noncarriers, 24.5 Median survival: p = 0.002 5-year survival for stage III and IV: p < 0.001 [46 ...

BRCA基因又分为BRCA1和BRCA2，BRCA1和BRCA2都是具有抑制恶性肿瘤发生的基因。也就是说，如果BRCA1或BRCA2发生了基因突变，就意味着患乳腺癌的风险加大了。

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a JAMA ...

The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

MRC Holland recently announced that five SALSA MLPA assays for the detection of hereditary breast and ovarian cancer (HBOC) ...

This was a huge step forward, but the statistics suggested that there was a significant amount of hereditary breast cancer not linked to the BRCA1 gene and the search for a second breast cancer gene ...

A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk patients ...